Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Alopecia Market Overview – 8 Major Markets
3.1 Alopecia Market Historical Value (2019-2025)
3.2 Alopecia Market Forecast Value (2026-2035)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Alopecia Disease Overview
5.1 Guidelines and Stages
5.2 Pathophysiology
5.3 Screening and Diagnosis
5.4 Treatment Pathway
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
6.3 Risk Assessment and Treatment Success Rate
7 Alopecia Epidemiology Scenario and Forecast – 8 Major Markets
7.1 8MM Epidemiology Scenario Overview (2019-2035)
7.2 Prevalence of Alopecia, by Country
7.2.1 United States
7.2.2 United Kingdom
7.2.3 Germany
7.2.4 France
7.2.5 Italy
7.2.6 Spain
7.2.7 India
7.2.8 Japan
7.3 Total Diagnosed Cases of Alopecia, by Country
7.4 Gender-specific Prevalence of Alopecia, by Country
7.5 Age-specific Prevalence of Kidney Alopecia, by Country
7.6 Treatment Seeking Rate of Alopecia, By Country
8 Alopecia Market Landscape – 8 Major Markets
8.1 Alopecia Market: Developers Landscape
8.1.1 Analysis by Year of Establishment
8.1.2 Analysis by Company Size
8.1.3 Analysis by Region
8.2 Alopecia Market: Product Landscape
8.2.1 Analysis by Disease Type
8.2.2 Analysis by Treatment
8.2.3 Analysis by Route of Administration
9 Clinical Trials and Pipeline Analysis
9.1 Analysis by Trial Registration Year
9.2 Analysis by Trial Status
9.3 Analysis by Trial Phase
9.4 Analysis by Therapeutic Area
9.5 Analysis by Geography
9.6 Drug Pipeline Assessment
10 Alopecia Market Challenges and Unmet Needs
10.1 Treatment Pathway Challenges
10.2 Compliance and Drop-Out Analysis
10.3 Awareness and Prevention Gaps
11 Cost of Treatment
12 Alopecia Market Dynamics
12.1 Market Drivers and Constraints
12.2 SWOT Analysis
12.2.1 Strengths
12.2.2 Weaknesses
12.2.3 Opportunities
12.2.4 Threats
12.3 PESTEL Analysis
12.3.1 Political
12.3.2 Economic
12.3.3 Social
12.3.4 Technological
12.3.5 Legal
12.3.6 Environment
12.4 Porter’s Five Forces Model
12.4.1 Bargaining Power of Suppliers
12.4.2 Bargaining Power of Buyers
12.4.3 Threat of New Entrants
12.4.4 Threat of Substitutes
12.4.5 Degree of Rivalry
12.5 Key Demand Indicators
12.6 Key Price Indicators
12.7 Industry Events, Initiatives, and Trends
12.8 Value Chain Analysis
13 Alopecia Market Segmentation (2019-2035) - 8 Major Markets
13.1 Alopecia Market (2019-2035) by Disease Type
13.1.1 Market Overview
13.1.2 Androgenic Alopecia
13.1.3 Alopecia Areata
13.1.4 Cicatricial Alopecia
13.1.5 Traction Alopecia
13.1.6 Alopecia Totalis
13.1.7 Others
13.2 Alopecia Market (2019-2035) by Treatment
13.2.1 Market Overview
13.2.2 Localized Therapies
13.2.3 Systemic Therapies
13.2.4 Medical Devices
13.2.5 Herbal Treatment
13.2.6 Others
13.3 Alopecia Market (2019-2035) by Route of Administration
13.3.1 Market Overview
13.3.2 Oral
13.3.3 Topical
13.3.4 Parenteral
13.4 Alopecia Market (2019-2035) by Gender
13.4.1 Market Overview
13.4.2 Males
13.4.3 Female
13.5 Alopecia Market (2019-2035) by End User
13.5.1 Market Overview
13.5.2 Hospitals
13.5.3 Healthcare and Dermatology Centers
13.5.4 Homecare
13.5.5 Others
13.6 Alopecia Market (2019-2035) by Distribution Channel
13.6.1 Market Overview
13.6.2 Hospital Pharmacy
13.6.3 Retail Pharmacy
13.6.4 Online Pharmacy
13.7 Alopecia Market (2019-2035) by Country
13.7.1 Market Overview
13.7.2 United States
13.7.3 United Kingdom
13.7.4 Germany
13.7.5 France
13.7.6 Italy
13.7.7 Spain
13.7.8 Japan
13.7.9 India
14 United States Alopecia Market (2019-2035)
14.1 United States Alopecia Market (2019-2035) by Disease Type
14.1.1 Market Overview
14.1.2 Androgenic Alopecia
14.1.3 Alopecia Areata
14.1.4 Cicatricial Alopecia
14.1.5 Traction Alopecia
14.1.6 Alopecia Totalis
14.1.7 Others
14.2 United States Alopecia Market (2019-2035) by Treatment
14.2.1 Market Overview
14.2.2 Localized Therapies
14.2.3 Systemic Therapies
14.2.4 Medical Devices
14.2.5 Herbal Treatment
14.2.6 Others
14.3 United States Alopecia Market (2019-2035) by Route of Administration
14.3.1 Market Overview
14.3.2 Oral
14.3.3 Topical
14.3.4 Parenteral
14.4 United States Alopecia Market (2019-2035) by Gender
14.4.1 Market Overview
14.4.2 Males
14.4.3 Female
14.5 United States Alopecia Market (2019-2035) by End User
14.5.1 Market Overview
14.5.2 Hospitals
14.5.3 Healthcare and Dermatology Centers
14.5.4 Homecare
14.5.5 Others
14.6 United States Alopecia Market (2019-2035) by Distribution Channel
14.6.1 Market Overview
14.6.2 Hospital Pharmacy
14.6.3 Retail Pharmacy
14.6.4 Online Pharmacy
15 United Kingdom Alopecia Market (2019-2035)
15.1 United Kingdom Alopecia Market (2019-2035) by Disease Type
15.1.1 Market Overview
15.1.2 Androgenic Alopecia
15.1.3 Alopecia Areata
15.1.4 Cicatricial Alopecia
15.1.5 Traction Alopecia
15.1.6 Alopecia Totalis
15.1.7 Others
15.2 United Kingdom Alopecia Market (2019-2035) by Treatment
15.2.1 Market Overview
15.2.2 Localized Therapies
15.2.3 Systemic Therapies
15.2.4 Medical Devices
15.2.5 Herbal Treatment
15.2.6 Others
15.3 United Kingdom Alopecia Market (2019-2035) by Route of Administration
15.3.1 Market Overview
15.3.2 Oral
15.3.3 Topical
15.3.4 Parenteral
15.4 United Kingdom Alopecia Market (2019-2035) by Gender
15.4.1 Market Overview
15.4.2 Males
15.4.3 Female
15.5 United Kingdom Alopecia Market (2019-2035) by End User
15.5.1 Market Overview
15.5.2 Hospitals
15.5.3 Healthcare and Dermatology Centers
15.5.4 Homecare
15.5.5 Others
15.6 United Kingdom Alopecia Market (2019-2035) by Distribution Channel
15.6.1 Market Overview
15.6.2 Hospital Pharmacy
15.6.3 Retail Pharmacy
15.6.4 Online Pharmacy
16 France Alopecia Market (2019-2035)
16.1 France Alopecia Market (2019-2035) by Disease Type
16.1.1 Market Overview
16.1.2 Androgenic Alopecia
16.1.3 Alopecia Areata
16.1.4 Cicatricial Alopecia
16.1.5 Traction Alopecia
16.1.6 Alopecia Totalis
16.1.7 Others
16.2 France Alopecia Market (2019-2035) by Treatment
16.2.1 Market Overview
16.2.2 Localized Therapies
16.2.3 Systemic Therapies
16.2.4 Medical Devices
16.2.5 Herbal Treatment
16.2.6 Others
16.3 France Alopecia Market (2019-2035) by Route of Administration
16.3.1 Market Overview
16.3.2 Oral
16.3.3 Topical
16.3.4 Parenteral
16.4 France Alopecia Market (2019-2035) by Gender
16.4.1 Market Overview
16.4.2 Males
16.4.3 Female
16.5 France Alopecia Market (2019-2035) by End User
16.5.1 Market Overview
16.5.2 Hospitals
16.5.3 Healthcare and Dermatology Centers
16.5.4 Homecare
16.5.5 Others
16.6 France Alopecia Market (2019-2035) by Distribution Channel
16.6.1 Market Overview
16.6.2 Hospital Pharmacy
16.6.3 Retail Pharmacy
16.6.4 Online Pharmacy
17 Italy Alopecia Market (2019-2035)
17.1 Italy Alopecia Market (2019-2035) by Disease Type
17.1.1 Market Overview
17.1.2 Androgenic Alopecia
17.1.3 Alopecia Areata
17.1.4 Cicatricial Alopecia
17.1.5 Traction Alopecia
17.1.6 Alopecia Totalis
17.1.7 Others
17.2 Italy Alopecia Market (2019-2035) by Treatment
17.2.1 Market Overview
17.2.2 Localized Therapies
17.2.3 Systemic Therapies
17.2.4 Medical Devices
17.2.5 Herbal Treatment
17.2.6 Others
17.3 Italy Alopecia Market (2019-2035) by Route of Administration
17.3.1 Market Overview
17.3.2 Oral
17.3.3 Topical
17.3.4 Parenteral
17.4 Italy Alopecia Market (2019-2035) by Gender
17.4.1 Market Overview
17.4.2 Males
17.4.3 Female
17.5 Italy Alopecia Market (2019-2035) by End User
17.5.1 Market Overview
17.5.2 Hospitals
17.5.3 Healthcare and Dermatology Centers
17.5.4 Homecare
17.5.5 Others
17.6 Italy Alopecia Market (2019-2035) by Distribution Channel
17.6.1 Market Overview
17.6.2 Hospital Pharmacy
17.6.3 Retail Pharmacy
17.6.4 Online Pharmacy
18 Spain Alopecia Market (2019-2035)
18.1 Spain Alopecia Market (2019-2035) by Disease Type
18.1.1 Market Overview
18.1.2 Androgenic Alopecia
18.1.3 Alopecia Areata
18.1.4 Cicatricial Alopecia
18.1.5 Traction Alopecia
18.1.6 Alopecia Totalis
18.1.7 Others
18.2 Spain Alopecia Market (2019-2035) by Treatment
18.2.1 Market Overview
18.2.2 Localized Therapies
18.2.3 Systemic Therapies
18.2.4 Medical Devices
18.2.5 Herbal Treatment
18.2.6 Others
18.3 Spain Alopecia Market (2019-2035) by Route of Administration
18.3.1 Market Overview
18.3.2 Oral
18.3.3 Topical
18.3.4 Parenteral
18.4 Spain Alopecia Market (2019-2035) by Gender
18.4.1 Market Overview
18.4.2 Males
18.4.3 Female
18.5 Spain Alopecia Market (2019-2035) by End User
18.5.1 Market Overview
18.5.2 Hospitals
18.5.3 Healthcare and Dermatology Centers
18.5.4 Homecare
18.5.5 Others
18.6 Spain Alopecia Market (2019-2035) by Distribution Channel
18.6.1 Market Overview
18.6.2 Hospital Pharmacy
18.6.3 Retail Pharmacy
18.6.4 Online Pharmacy
19 Japan Alopecia Market
19.1 Japan Alopecia Market (2019-2035) by Disease Type
19.1.1 Market Overview
19.1.2 Androgenic Alopecia
19.1.3 Alopecia Areata
19.1.4 Cicatricial Alopecia
19.1.5 Traction Alopecia
19.1.6 Alopecia Totalis
19.1.7 Others
19.2 Japan Alopecia Market (2019-2035) by Treatment
19.2.1 Market Overview
19.2.2 Localized Therapies
19.2.3 Systemic Therapies
19.2.4 Medical Devices
19.2.5 Herbal Treatment
19.2.6 Others
19.3 Japan Alopecia Market (2019-2035) by Route of Administration
19.3.1 Market Overview
19.3.2 Oral
19.3.3 Topical
19.3.4 Parenteral
19.4 Japan Alopecia Market (2019-2035) by Gender
19.4.1 Market Overview
19.4.2 Males
19.4.3 Female
19.5 Japan Alopecia Market (2019-2035) by End User
19.5.1 Market Overview
19.5.2 Hospitals
19.5.3 Healthcare and Dermatology Centers
19.5.4 Homecare
19.5.5 Others
19.6 Japan Alopecia Market (2019-2035) by Distribution Channel
19.6.1 Market Overview
19.6.2 Hospital Pharmacy
19.6.3 Retail Pharmacy
19.6.4 Online Pharmacy
20 India Alopecia Market
20.1 India Alopecia Market (2019-2035) by Disease Type
20.1.1 Market Overview
20.1.2 Androgenic Alopecia
20.1.3 Alopecia Areata
20.1.4 Cicatricial Alopecia
20.1.5 Traction Alopecia
20.1.6 Alopecia Totalis
20.1.7 Others
20.2 India Alopecia Market (2019-2035) by Treatment
20.2.1 Market Overview
20.2.2 Localized Therapies
20.2.3 Systemic Therapies
20.2.4 Medical Devices
20.2.5 Herbal Treatment
20.2.6 Others
20.3 India Alopecia Market (2019-2035) by Route of Administration
20.3.1 Market Overview
20.3.2 Oral
20.3.3 Topical
20.3.4 Parenteral
20.4 India Alopecia Market (2019-2035) by Gender
20.4.1 Market Overview
20.4.2 Males
20.4.3 Female
20.5 India Alopecia Market (2019-2035) by End User
20.5.1 Market Overview
20.5.2 Hospitals
20.5.3 Healthcare and Dermatology Centers
20.5.4 Homecare
20.5.5 Others
20.6 India Alopecia Market (2019-2035) by Distribution Channel
20.6.1 Market Overview
20.6.2 Hospital Pharmacy
20.6.3 Retail Pharmacy
20.6.4 Online Pharmacy
21 Regulatory Framework
21.1 Regulatory Overview
21.2 US FDA
21.3 EU EMA
21.4 Japan PMDA
21.5 India CDSCO
21.6 Others
22 Patent Analysis
22.1 Analysis by Type of Technology
22.2 Analysis by Publication Year
22.3 Analysis by Issuing Authority
22.4 Analysis by Patent Age
22.5 Analysis by CPC Codes
22.6 Analysis by Patent Valuation
22.7 Analysis by Key Players
23 Grants Analysis
23.1 Analysis by Year
23.2 Analysis by Amount Awarded
23.3 Analysis by Issuing Authority
23.4 Analysis by Grant Application
23.5 Analysis by Funding Institute
23.6 Analysis by NIH Departments
23.7 Analysis by Recipient Organization
24 Funding and Investment Analysis
24.1 Analysis by Funding Instances
24.2 Analysis by Type of Funding
24.3 Analysis by Funding Amount
24.4 Analysis by Leading Players
24.5 Analysis by Leading Investors
24.6 Analysis by Geography
25 Strategic Initiatives
25.1 Analysis by Partnership Instances
25.2 Analysis by Type of Initiatives
25.3 Analysis by Leading Players
25.4 Analysis by Geography
26 Supplier Landscape
26.1 Market Share by Top 5 Companies
26.2 Cipla Ltd.
26.2.1 Financial Analysis
26.2.2 Product Portfolio
26.2.3 Demographic Reach and Achievements
26.2.4 Company News and Development
26.2.5 Certifications
26.3 Capillus LLC
26.3.1 Financial Analysis
26.3.2 Product Portfolio
26.3.3 Demographic Reach and Achievements
26.3.4 Company News and Development
26.3.5 Certifications
26.4 Freedom Laser Therapy, Inc.
26.4.1 Financial Analysis
26.4.2 Product Portfolio
26.4.3 Demographic Reach and Achievements
26.4.4 Company News and Development
26.4.5 Certifications
26.5 Apira Science, Inc.
26.5.1 Financial Analysis
26.5.2 Product Portfolio
26.5.3 Demographic Reach and Achievements
26.5.4 Company News and Development
26.5.5 Certifications
26.6 HairMax (Lexington Intl., LLC)
26.6.1 Financial Analysis
26.6.2 Product Portfolio
26.6.3 Demographic Reach and Achievements
26.6.4 Company News and Development
26.6.5 Certifications
26.7 Follica, Inc.
26.7.1 Financial Analysis
26.7.2 Product Portfolio
26.7.3 Demographic Reach and Achievements
26.7.4 Company News and Development
26.7.5 Certifications
26.8 Incyte Corporation
26.8.1 Financial Analysis
26.8.2 Product Portfolio
26.8.3 Demographic Reach and Achievements
26.8.4 Company News and Development
26.8.5 Certifications
26.9 Novartis AG
26.9.1 Financial Analysis
26.9.2 Product Portfolio
26.9.3 Demographic Reach and Achievements
26.9.4 Company News and Development
26.9.5 Certifications
26.10 Sanofi S.A.
26.10.1 Financial Analysis
26.10.2 Product Portfolio
26.10.3 Demographic Reach and Achievements
26.10.4 Company News and Development
26.10.5 Certifications
26.11 Merck & Co. Inc.
26.11.1 Financial Analysis
26.11.2 Product Portfolio
26.11.3 Demographic Reach and Achievements
26.11.4 Company News and Development
26.11.5 Certifications
26.12 Gerolymatos International SA
26.12.1 Financial Analysis
26.12.2 Product Portfolio
26.12.3 Demographic Reach and Achievements
26.12.4 Company News and Development
26.12.5 Certifications
26.13 Taisho Pharmaceutical Holdings Co., Ltd.
26.13.1 Financial Analysis
26.13.2 Product Portfolio
26.13.3 Demographic Reach and Achievements
26.13.4 Company News and Development
26.13.5 Certifications
26.14 Teva Pharmaceuticals, Inc.
26.14.1 Financial Analysis
26.14.2 Product Portfolio
26.14.3 Demographic Reach and Achievements
26.14.4 Company News and Development
26.14.5 Certifications
27 Key Opinion Leaders (KOL) Insights (Additional Insight)
*The list of players in the competitive landscape section can be customised or made more exhaustive based on your specific requirements.*